[Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
D000244:Adenosine Diphosphate / Q000502:physiology; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D000242:Cyclic AMP / Q000502:physiology; D003911:Dextrans / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D006801:Humans; D006886:Hydroxychloroquine / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000502:physiology; D013442:Sulfinpyrazone / Q000494:pharmacology; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control*; D013928:Thromboxane A2 / Q000502:physiology
D003911:Dextrans; D011453:Prostaglandins; D006886:Hydroxychloroquine; D013928:Thromboxane A2; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D000242:Cyclic AMP; D001241:Aspirin; D013442:Sulfinpyrazone; D007213:Indomethacin
Tromboseprofylakse med trombocytfunktionshaemmere. 1. Cellulaere regulationsmekanismer og farmakologiske angrebspunkter.